<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Clinical nutrition and metabolism</journal-id><journal-title-group><journal-title xml:lang="en">Clinical nutrition and metabolism</journal-title><trans-title-group xml:lang="ru"><trans-title>Клиническое питание и метаболизм</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2658-4433</issn><issn publication-format="electronic">2782-2974</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81626</article-id><article-id pub-id-type="doi">10.17816/clinutr81626</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Editorial</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Редакционные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Perioperative infusion therapy</article-title><trans-title-group xml:lang="ru"><trans-title>Периоперационная инфузионная терапия</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2815-5277</contrib-id><contrib-id contrib-id-type="spin">8951-9550</contrib-id><name-alternatives><name xml:lang="en"><surname>Skobelev</surname><given-names>Evgeny I.</given-names></name><name xml:lang="ru"><surname>Скобелев</surname><given-names>Евгений Иванович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.), Associate Professor</p></bio><bio xml:lang="ru"><p>к.м.н., доцент</p></bio><email>89037778864@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8121-4160</contrib-id><contrib-id contrib-id-type="spin">4433-1418</contrib-id><name-alternatives><name xml:lang="en"><surname>Pasechnik</surname><given-names>Igor N.</given-names></name><name xml:lang="ru"><surname>Пасечник</surname><given-names>Игорь Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>pasigor@ya.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Central State Medical Academy of Department of Presidential Affairs</institution></aff><aff><institution xml:lang="ru">Центральная государственная медицинская академия Управления делами Президента Российской Федерации</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2021-12-19" publication-format="electronic"><day>19</day><month>12</month><year>2021</year></pub-date><pub-date date-type="pub" iso-8601-date="2021-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2021</year></pub-date><volume>2</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>100</fpage><lpage>108</lpage><history><date date-type="received" iso-8601-date="2021-10-03"><day>03</day><month>10</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-12-10"><day>10</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Skobelev E.I., Pasechnik I.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Скобелев Е.И., Пасечник И.Н.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Skobelev E.I., Pasechnik I.N.</copyright-holder><copyright-holder xml:lang="ru">Скобелев Е.И., Пасечник И.Н.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/2658-4433/article/view/81626">https://journals.eco-vector.com/2658-4433/article/view/81626</self-uri><abstract xml:lang="en"><p>Perioperative infusion support of surgical patients is the main and non-alternative element of treatment.</p> <p>At the same time, the tactics of infusion therapy continues to be the subject of study. Ideas about the optimal quantitative and qualitative composition of the fluid transfused to patients are being revised as ideas about the pathogenesis of critical conditions evolve. The basis of pathogenetic analysis of compensatory hemodynamic capabilities, as a point of application of infusion treatment, previously consisted mainly of invasive monitoring techniques, replaced in recent years by the control of routine parameters with proven high correlation with invasive ones. In current studies devoted to the problems of infusion correction of hemodynamic abnormalities, the most discussed issues are the applicability of isotonic and balanced polyionic crystalloids, less often colloidal solutions in various clinical situations, and the results of such studies do not always allow to unambiguously determine the choice of infusion media, and sometimes simply incomparable. Some researchers advocate the use of isotonic crystalloids, some works prove the best effectiveness of balanced salt solutions. With the volumes of treatment corresponding to the perioperative period, in most studies there are no differences in the effectiveness of the main composite groups of crystalloids at all. We see the reason for this in the peculiarities of randomization methods, when statistical limitations do not allow us to avoid discrete data analysis: their comparative grouping occurs according to the principle of selecting a target parameter, and all the others are classified as auxiliary or secondary. It seems to us that the involvement of arrays of data obtained in real clinical practice as a result of a combination of local theoretical and empirical ideas about corrective treatment regimens correlated with their effectiveness could smooth out the inconsistency of the results of such studies, especially since clinicians have a sample with a volemic load at their disposal, allowing them to predict the hemodynamic reaction of the patient's body to infusion and a set of routine parameters for more fine-tuning of therapy.</p> <p>In anesthesiological and resuscitation practice, there is an opinion of the currently popular empirical-evidence plan that balanced salt solutions are preferable to isotonic solutions with a higher degree of severity of patients, but this opinion is not a priori and requires additional research to verify the choice.</p></abstract><trans-abstract xml:lang="ru"><p>Периоперационное инфузионное сопровождение хирургических пациентов является основным и безальтернативным элементом лечения, при этом тактика инфузионной терапии продолжает оставаться предметом изучения.</p> <p>Точки зрения об оптимальном количественном и качественном составе переливаемой пациентам жидкости подвергаются пересмотру по мере эволюции представлений о патогенезе критических состояний. Основу патогенетического анализа компенсаторных возможностей гемодинамики как точки приложения инфузионного лечения ранее составляли преимущественно методики инвазивного мониторирования, сменяемые в последние годы контролем рутинных параметров с доказанным высоким корреляционным соответствием. В актуальных исследованиях, посвящённых проблемам инфузионной коррекции гемодинамических отклонений, наиболее обсуждают вопросы применимости изотонических и сбалансированных полиионных кристаллоидов, реже коллоидных растворов в различных клинических ситуациях, причём результаты таких исследований не всегда позволяют однозначно определиться с выбором инфузионных сред, а иногда просто малосравнимы. Часть исследователей ратует за применение изотонических кристаллоидов, другие доказывают лучшую эффективность сбалансированных солевых растворов. При объёмах лечения, соответствующих периоперационному периоду, в большинстве работ различий в эффективности основных композиционных групп кристаллоидов вообще не отмечают. Причину этого мы видим в особенностях способов рандомизации, когда статистические ограничения не позволяют избежать дискретного анализа данных: их сравнительная группировка происходит по принципу выбора целевого параметра, а все остальные относят к вспомогательным или второстепенным. Сгладить противоречивость результатов таких исследований, как нам кажется, могло бы привлечение массивов данных, полученных в реальной клинической практике в результате сочетания локальных теоретических и эмпирических представлений о корригирующих схемах лечения, соотнесённых с их эффективностью, тем более что в распоряжении клиницистов есть проба с волемической нагрузкой, позволяющая предугадывать гемодинамическую реакцию организма пациента на инфузию и набор рутинных параметров для более тонкой индивидуальной настройки терапии.</p> <p>В анестезиолого-реанимационной практике существует мнение популярного в настоящее время эмпирически-доказательного плана, что сбалансированные солевые растворы предпочтительнее изотонических при более высокой степени тяжести больных, но это мнение не является априорным и требует дополнительных исследований с целью верификации выбора.</p></trans-abstract><kwd-group xml:lang="en"><kwd>hemodynamics</kwd><kwd>volemia</kwd><kwd>crystalloids</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гемодинамика</kwd><kwd>волемия</kwd><kwd>кристаллоиды</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Connor JM, Coopersmith CM. Does crystalloid composition or rate of fluid administration make a difference when resuscitating patients in the ICU? JAMA. 2021. doi: 10.1001/jama.2021.11119</mixed-citation><mixed-citation xml:lang="ru">Connor J.M., Coopersmith C.M. Does crystalloid composition or rate of fluid administration make a difference when resuscitating patients in the ICU? // JAMA. 2021. doi: 10.1001/jama.2021.11119</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Rivers E, Nguyen B, Havstad S, et al.; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–1377. doi: 10.1056/NEJMoa010307</mixed-citation><mixed-citation xml:lang="ru">Rivers E., Nguyen B., Havstad S., et al.; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock // N Engl J Med. 2001. Vol. 345, N 19. Р. 1368–1377. doi: 10.1056/NEJMoa010307</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Yealy DM, Kellum JA, Huang DT, et al.; ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–1693. doi: 10.1056/NEJMoa1401602</mixed-citation><mixed-citation xml:lang="ru">Yealy D.M., Kellum J.A., Huang D.T., et al.; ProCESS Investigators. A randomized trial of protocol-based care for early septic shock // N Engl J Med. 2014. Vol. 370, N 18. Р. 1683–1693. doi: 10.1056/NEJMoa1401602</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100. doi: 10.1186/s13054-016-1265-x</mixed-citation><mixed-citation xml:lang="ru">Rossaint R., Bouillon B., Cerny V., et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition // Crit Care. 2016. Vol. 20. Р. 100. doi: 10.1186/s13054-016-1265-x</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Pasechnik IN, Funny IA, Timashkov DA, et al. Planned surgical intervention and oral loading with carbohydrates. Surgery Magazine Named After N.I. Pirogov. 2020;(6):82–89. (In Russ). doi: 10.17116/hirurgia202006182</mixed-citation><mixed-citation xml:lang="ru">Пасечник И.Н., Смешной И.А., Тимашков Д.А., и др. Плановое хирургическое вмешательство и пероральная нагрузка углеводами // Хирургия. Журнал имени Н.И. Пирогова. 2020. № 6. С. 82–89. doi: 10.17116/hirurgia202006182</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Funny IA, Pasechnik IN, Skobelev EI, et al. Optimization of infusion therapy in planned abdominal surgery. General Resuscitation. 2018;14(5):4–15. (In Russ). doi: 10.15360/1813-9779-2018-5-4-15</mixed-citation><mixed-citation xml:lang="ru">Смешной И.А., Пасечник И.Н., Скобелев Е.И., и др. Оптимизация инфузионной терапии в плановой абдоминальной хирургии // Общая реаниматология. 2018. Т. 14, № 5. С. 4–15. doi: 10.15360/1813-9779-2018-5-4-15</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Weil MH, Henning RJ. New concepts in the diagnosis and fluid treatment of circulatory shock. In: 13th annual becton, dickinson and company oscar schwidetsky memorial lecture. Anesth Analg. 1979;58(2):124–132.</mixed-citation><mixed-citation xml:lang="ru">Weil M.H., Henning R.J. New concepts in the diagnosis and fluid treatment of circulatory shock. In: 13th annual becton, dickinson and company oscar schwidetsky memorial lecture // Anesth Analg. 1979. Vol. 58, N 2. Р. 124–132.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Vincent JL, Weil MH. Fluid challenge revisited. Crit Care Med. 2006;34(5):1333–1337. doi: 1097/01.CCM.0000214677.76535.A5</mixed-citation><mixed-citation xml:lang="ru">Vincent J.L., Weil M.H. Fluid challenge revisited // Crit Care Med. 2006. Vol. 34, N 5. Р. 1333–1337. doi: 1097/01.CCM.0000214677.76535.A5</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Heenen S, De Backer D, Vincent JL. How can the response to volume expansion in patients with spontaneous respiratory movements be predicted? Crit Care. 2006;10(4):R102. doi: 10.1186/cc4970</mixed-citation><mixed-citation xml:lang="ru">Heenen S., De Backer D., Vincent J.L. How can the response to volume expansion in patients with spontaneous respiratory movements be predicted? // Crit Care. 2006. Vol. 10, N 4. Р. R102. doi: 10.1186/cc4970</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Aya HD, Ster IC, Fletcher N, et al. Pharmacodynamic analysis of a fluid challenge. Crit Care Med. 2016;44(5):880–891. doi: 10.1097/CCM.0000000000001517</mixed-citation><mixed-citation xml:lang="ru">Aya H.D., Ster I.C., Fletcher N., et al. Pharmacodynamic analysis of a fluid challenge // Crit Care Med. 2016. Vol. 44, N 5. Р. 880–891. doi: 10.1097/CCM.0000000000001517</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Aya HD, Rhodes A, Chis SI, et al. Hemodynamic effect of different doses of fluids for a fluid challenge: a quasi-randomized controlled study. Crit Care Med. 2017;45(2):e161–168. doi: 10.1097/CCM.0000000000002067</mixed-citation><mixed-citation xml:lang="ru">Aya H.D., Rhodes A., Chis S.I., et al. Hemodynamic effect of different doses of fluids for a fluid challenge: a quasi-randomized controlled study // Crit Care Med. 2017. Vol. 45, N 2. Р. e161–168. doi: 10.1097/CCM.0000000000002067</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Toscani L, Aya HD, Antonakaki D, et al. What is the impact of the fluid challenge technique on diagnosis of fluid responsiveness? A systematic review and meta-analysis. Crit Care. 2017;21(1):207. doi: 10.1186/s13054-017-1796-9</mixed-citation><mixed-citation xml:lang="ru">Toscani L., Aya H.D., Antonakaki D., et al. What is the impact of the fluid challenge technique on diagnosis of fluid responsiveness? A systematic review and meta-analysis // Crit Care. 2017. Vol. 21, N 1. Р. 207. doi: 10.1186/s13054-017-1796-9</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Biais M, De CH, Lanchon R, et al. Mini-fluid challenge of 100 ml of crystalloid predicts fluid responsiveness in the operating room. Anesthesiology. 2017;127(3):450–456. doi: 10.1097/ALN.0000000000001753</mixed-citation><mixed-citation xml:lang="ru">Biais M., De C.H., Lanchon R., et al. Mini-fluid challenge of 100 ml of crystalloid predicts fluid responsiveness in the operating room // Anesthesiology. 2017. Vol. 127, N 3. Р. 450–456. doi: 10.1097/ALN.0000000000001753</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Jozwiak M, Mercado P, Teboul JL, et al. What is the lowest change in cardiac output that transthoracic echocar-diography can detect? Crit Care. 2019;23(1):116. doi: 10.1186/s13054-019-2413-x</mixed-citation><mixed-citation xml:lang="ru">Jozwiak M., Mercado P., Teboul J.L., et al. What is the lowest change in cardiac output that transthoracic echocar-diography can detect? // Crit Care. 2019. Vol. 23, N 1. Р. 116. doi: 10.1186/s13054-019-2413-x</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552. doi: 10.1097/CCM. 0000000000002255</mixed-citation><mixed-citation xml:lang="ru">Rhodes A., Evans L.E., Alhazzani W., et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016 // Crit Care Med. 2017. Vol. 45, N 3. Р. 486–552. doi: 10.1097/CCM. 0000000000002255</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Finfer S, Bellomo R, Boyce N, et al.; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247–2256. doi: 10.1056/NEJMoa040232</mixed-citation><mixed-citation xml:lang="ru">Finfer S., Bellomo R., Boyce N., et al.; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit // N Engl J Med. 2004. Vol. 350, N 22. Р. 2247–2256. doi: 10.1056/NEJMoa040232</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and Plasma-Lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256(1):18–24. doi: 10. 1097/SLA.0b013e318256be72</mixed-citation><mixed-citation xml:lang="ru">Chowdhury A.H., Cox E.F., Francis S.T., Lobo D.N. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and Plasma-Lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers // Ann Surg. 2012. Vol. 256, N 1. Р. 18–24. doi: 10. 1097/SLA.0b013e318256be72</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Young P, Bailey M, Beasley R, et al.; SPLIT Investigators; ANZICS CTG. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA. 2015;314(16):1701–1710. doi: 10.1001/jama.2015.12334</mixed-citation><mixed-citation xml:lang="ru">Young P., Bailey M., Beasley R., et al.; SPLIT Investigators; ANZICS CTG. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial // JAMA. 2015. Vol. 314, N 16. Р. 1701–1710. doi: 10.1001/jama.2015.12334</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Semler MW, Self WH, Wanderer JP, et al.; SMART Investigators and the Pragmatic Critical Care Research Group. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378(9):829–839. doi: 10.1056/NEJMoa1711584</mixed-citation><mixed-citation xml:lang="ru">Semler M.W., Self W.H., Wanderer J.P., et al.; SMART Investigators and the Pragmatic Critical Care Research Group. Balanced crystalloids versus saline in critically ill adults // N Engl J Med. 2018. Vol. 378, N 9. Р. 829–839. doi: 10.1056/NEJMoa1711584</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Zampieri FG, Machado FR, Biondi RS, et al.; BaSICS investigators and BRICNet members. Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial. JAMA. 2021;326(9): 1–12. doi: 10.1001/jama.2021.11684</mixed-citation><mixed-citation xml:lang="ru">Zampieri F.G., Machado F.R., Biondi R.S., et al.; BaSICS investigators and BRICNet members. Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial // JAMA. 2021. Vol. 326, N 9. Р. 1–12. doi: 10.1001/jama.2021.11684</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Zampieri FG, Machado FR, Biondi RS, et al.; BaSICS investigators and BRICNet members. Effect of slower vs faster intravenous fluid bolus rates on mortality in critically ill patients: the BaSICS randomized clinical trial. JAMA. 2021;326(9):830–838. doi: 10.1001/jama.2021.11444</mixed-citation><mixed-citation xml:lang="ru">Zampieri F.G., Machado F.R., Biondi R.S., et al.; BaSICS investigators and BRICNet members. Effect of slower vs faster intravenous fluid bolus rates on mortality in critically ill patients: the BaSICS randomized clinical trial // JAMA. 2021. Vol. 326, N 9. Р. 830–838. doi: 10.1001/jama.2021.11444</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg. 2012;255(5): 821–829. doi: 10.1097/SLA.0b013e31825074f5</mixed-citation><mixed-citation xml:lang="ru">Shaw A.D., Bagshaw S.M., Goldstein S.L., et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte // Ann Surg. 2012. Vol. 255, N 5. Р. 821–829. doi: 10.1097/SLA.0b013e31825074f5</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308(15):1566–1572. doi: 10.1001/jama.2012.13356</mixed-citation><mixed-citation xml:lang="ru">Yunos N.M., Bellomo R., Hegarty C., et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults // JAMA. 2012. Vol. 308, N 15. Р. 1566–1572. doi: 10.1001/jama.2012.13356</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Krajewski ML, Raghunathan K, Paluszkiewicz SM, et al. Meta- analysis of high-versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg. 2015;102(1):24–36. doi: 10.1002/bjs.9651</mixed-citation><mixed-citation xml:lang="ru">Krajewski M.L., Raghunathan K., Paluszkiewicz S.M., et al. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation // Br J Surg. 2015. Vol. 102, N 1. Р. 24–36. doi: 10.1002/bjs.9651</mixed-citation></citation-alternatives></ref></ref-list></back></article>
